NVS
Novartis AG ADR
NYSE: NVS · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$147.85
+3.44% today
Updated 2026-04-30
Market cap
$282.11B
P/E ratio
21.18
P/S ratio
4.99x
EPS (TTM)
$6.98
Dividend yield
3.21%
52W range
$102 – $165
Volume
2.1M
Novartis AG ADR (NVS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
23.90%
Operating margin
30.50%
ROE
34.90%
ROA
10.50%
Debt/equity
0.80x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $35.10B | $7.17B | 73.19% | 21.77% | 20.44% |
| 2007 | $38.95B | $11.95B | 71.67% | 17.41% | 30.67% |
| 2008 | $42.58B | $8.20B | 73.14% | 21.05% | 19.24% |
| 2009 | $45.10B | $8.40B | 73.00% | 22.13% | 18.62% |
| 2010 | $51.56B | $9.79B | 71.90% | 22.35% | 18.99% |
| 2011 | $59.38B | $8.94B | 68.03% | 18.16% | 15.06% |
| 2012 | $51.97B | $9.27B | 69.47% | 22.14% | 17.84% |
| 2013 | $52.72B | $9.18B | 68.55% | 20.83% | 17.40% |
| 2014 | $53.63B | $10.21B | 67.66% | 20.68% | 19.04% |
| 2015 | $50.39B | $17.78B | 65.46% | 17.82% | 35.29% |
| 2016 | $49.44B | $6.71B | 64.56% | 16.72% | 13.58% |
| 2017 | $43.40B | $7.70B | 68.59% | 20.05% | 17.75% |
| 2018 | $46.10B | $12.61B | 68.52% | 18.23% | 27.36% |
| 2019 | $48.68B | $11.73B | 70.37% | 18.67% | 24.10% |
| 2020 | $49.90B | $8.07B | 69.70% | 20.35% | 16.18% |
| 2021 | $43.97B | $24.02B | 73.31% | 22.87% | 54.63% |
| 2022 | $43.46B | $6.96B | 73.35% | 18.28% | 16.00% |
| 2023 | $46.66B | $14.85B | 73.27% | 20.94% | 31.83% |
| 2024 | $51.72B | $11.94B | 75.20% | 28.12% | 23.09% |
| 2025 | $54.81B | $14.06B | 75.02% | 31.15% | 25.64% |